Cargando…
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), initially originated in China in year 2019 and spread rapidly across the globe within 5 months, causing over 96 million cases of infection and over 2 million deaths. Huge efforts were undertaken to bring the COVID-19 vaccines in clinical...
Autores principales: | Dey, Ayan, Chozhavel Rajanathan, T.M., Chandra, Harish, Pericherla, Hari P.R., Kumar, Sanjeev, Choonia, Huzaifa S., Bajpai, Mayank, Singh, Arun K., Sinha, Anuradha, Saini, Gurwinder, Dalal, Parth, Vandriwala, Sarosh, Raheem, Mohammed A., Divate, Rupesh D., Navlani, Neelam L., Sharma, Vibhuti, Parikh, Aashini, Prasath, Siva, Sankar Rao, M., Maithal, Kapil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166516/ https://www.ncbi.nlm.nih.gov/pubmed/34120764 http://dx.doi.org/10.1016/j.vaccine.2021.05.098 |
Ejemplares similares
-
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India
por: Momin, Taufik, et al.
Publicado: (2021) -
Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India
por: Khobragade, Akash, et al.
Publicado: (2022) -
Research on the Trajectory Model for ZY-3
por: Chen, Yifu, et al.
Publicado: (2014) -
Comparative highlights on MERS-CoV, SARS-CoV-1, SARS-CoV-2, and NEO-CoV
por: Goyal, Rajat, et al.
Publicado: (2022) -
VBS/VBF measurements (with photons Wy/Zy) at ATLAS and CMS
por: Smart, Ben Harry
Publicado: (2021)